180 related articles for article (PubMed ID: 29207576)
1. Glycosaminoglycan-Mediated Downstream Signaling of CXCL8 Binding to Endothelial Cells.
Derler R; Gesslbauer B; Weber C; Strutzmann E; Miller I; Kungl A
Int J Mol Sci; 2017 Dec; 18(12):. PubMed ID: 29207576
[TBL] [Abstract][Full Text] [Related]
2. Heparin-bound chemokine CXCL8 monomer and dimer are impaired for CXCR1 and CXCR2 activation: implications for gradients and neutrophil trafficking.
Joseph PRB; Sawant KV; Rajarathnam K
Open Biol; 2017 Nov; 7(11):. PubMed ID: 29118271
[TBL] [Abstract][Full Text] [Related]
3. PA401, a novel CXCL8-based biologic therapeutic with increased glycosaminoglycan binding, reduces bronchoalveolar lavage neutrophils and systemic inflammatory markers in a murine model of LPS-induced lung inflammation.
Adage T; Del Bene F; Fiorentini F; Doornbos RP; Zankl C; Bartley MR; Kungl AJ
Cytokine; 2015 Dec; 76(2):433-441. PubMed ID: 26303011
[TBL] [Abstract][Full Text] [Related]
4. Induction of a CXCL8 binding site on endothelial syndecan-3 in rheumatoid synovium.
Patterson AM; Gardner L; Shaw J; David G; Loreau E; Aguilar L; Ashton BA; Middleton J
Arthritis Rheum; 2005 Aug; 52(8):2331-42. PubMed ID: 16052590
[TBL] [Abstract][Full Text] [Related]
5. Targeting glycosaminoglycans in the lung by an engineered CXCL8 as a novel therapeutic approach to lung inflammation.
Adage T; Konya V; Weber C; Strutzmann E; Fuchs T; Zankl C; Gerlza T; Jeremic D; Heinemann A; Kungl AJ
Eur J Pharmacol; 2015 Feb; 748():83-92. PubMed ID: 25554213
[TBL] [Abstract][Full Text] [Related]
6. A C-terminal CXCL8 peptide based on chemokine-glycosaminoglycan interactions reduces neutrophil adhesion and migration during inflammation.
Martínez-Burgo B; Cobb SL; Pohl E; Kashanin D; Paul T; Kirby JA; Sheerin NS; Ali S
Immunology; 2019 Jun; 157(2):173-184. PubMed ID: 31013364
[TBL] [Abstract][Full Text] [Related]
7. Monomeric and dimeric CXCL8 are both essential for in vivo neutrophil recruitment.
Das ST; Rajagopalan L; Guerrero-Plata A; Sai J; Richmond A; Garofalo RP; Rajarathnam K
PLoS One; 2010 Jul; 5(7):e11754. PubMed ID: 20668677
[TBL] [Abstract][Full Text] [Related]
8. A Requirement for Neutrophil Glycosaminoglycans in Chemokine:Receptor Interactions Is Revealed by the Streptococcal Protease SpyCEP.
Goldblatt J; Lawrenson RA; Muir L; Dattani S; Hoffland A; Tsuchiya T; Kanegasaki S; Sriskandan S; Pease JE
J Immunol; 2019 Jun; 202(11):3246-3255. PubMed ID: 31010851
[TBL] [Abstract][Full Text] [Related]
9. Human Brain Endothelial CXCR2 is Inflammation-Inducible and Mediates CXCL5- and CXCL8-Triggered Paraendothelial Barrier Breakdown.
Haarmann A; Schuhmann MK; Silwedel C; Monoranu CM; Stoll G; Buttmann M
Int J Mol Sci; 2019 Jan; 20(3):. PubMed ID: 30704100
[TBL] [Abstract][Full Text] [Related]
10. Glycosaminoglycans located on neutrophils and monocytes impact on CXCL8- and CCL2-induced cell migration.
Gerlza T; Nagele M; Mihalic Z; Trojacher C; Kungl A
Cytokine; 2021 Jun; 142():155503. PubMed ID: 33781652
[TBL] [Abstract][Full Text] [Related]
11. Glycosaminoglycans are important mediators of neutrophilic inflammation in vivo.
Gschwandtner M; Strutzmann E; Teixeira MM; Anders HJ; Diedrichs-Möhring M; Gerlza T; Wildner G; Russo RC; Adage T; Kungl AJ
Cytokine; 2017 Mar; 91():65-73. PubMed ID: 28011398
[TBL] [Abstract][Full Text] [Related]
12. Designing CXCL8-based decoy proteins with strong anti-inflammatory activity in vivo.
Falsone A; Wabitsch V; Geretti E; Potzinger H; Gerlza T; Robinson J; Adage T; Teixeira MM; Kungl AJ
Biosci Rep; 2013 Sep; 33(5):. PubMed ID: 23919527
[TBL] [Abstract][Full Text] [Related]
13. Syndecan-4-dependent signaling in the inhibition of endotoxin-induced endothelial adherence of neutrophils by antithrombin.
Kaneider NC; Förster E; Mosheimer B; Sturn DH; Wiedermann CJ
Thromb Haemost; 2003 Dec; 90(6):1150-7. PubMed ID: 14652650
[TBL] [Abstract][Full Text] [Related]
14. CXCL8-induced FAK phosphorylation via CXCR1 and CXCR2: cytoskeleton- and integrin-related mechanisms converge with FAK regulatory pathways in a receptor-specific manner.
Cohen-Hillel E; Yron I; Meshel T; Soria G; Attal H; Ben-Baruch A
Cytokine; 2006 Jan; 33(1):1-16. PubMed ID: 16406804
[TBL] [Abstract][Full Text] [Related]
15. The Anti-inflammatory Protein TSG-6 Regulates Chemokine Function by Inhibiting Chemokine/Glycosaminoglycan Interactions.
Dyer DP; Salanga CL; Johns SC; Valdambrini E; Fuster MM; Milner CM; Day AJ; Handel TM
J Biol Chem; 2016 Jun; 291(24):12627-12640. PubMed ID: 27044744
[TBL] [Abstract][Full Text] [Related]
16. The chemokines CXCL8 and CXCL12: molecular and functional properties, role in disease and efforts towards pharmacological intervention.
Cambier S; Gouwy M; Proost P
Cell Mol Immunol; 2023 Mar; 20(3):217-251. PubMed ID: 36725964
[TBL] [Abstract][Full Text] [Related]
17. Combined anti CXC receptors 1 and 2 therapy is a promising anti-inflammatory treatment for respiratory diseases by reducing neutrophil migration and activation.
Planagumà A; Domènech T; Pont M; Calama E; García-González V; López R; Aulí M; López M; Fonquerna S; Ramos I; de Alba J; Nueda A; Prats N; Segarra V; Miralpeix M; Lehner MD
Pulm Pharmacol Ther; 2015 Oct; 34():37-45. PubMed ID: 26271598
[TBL] [Abstract][Full Text] [Related]
18. Matrix glycosaminoglycans in the growth phase of fibroblasts: more of the story in wound healing.
Kosir MA; Quinn CC; Wang W; Tromp G
J Surg Res; 2000 Jul; 92(1):45-52. PubMed ID: 10864481
[TBL] [Abstract][Full Text] [Related]
19. Immobilisation of CXCL8 gradients in microfluidic devices for migration experiments.
Kilb MF; Engemann VI; Siddique A; Stark RW; Schmitz K
Colloids Surf B Biointerfaces; 2021 Feb; 198():111498. PubMed ID: 33302150
[TBL] [Abstract][Full Text] [Related]
20. Lung endothelial heparan sulfates mediate cationic peptide-induced barrier dysfunction: a new role for the glycocalyx.
Dull RO; Dinavahi R; Schwartz L; Humphries DE; Berry D; Sasisekharan R; Garcia JG
Am J Physiol Lung Cell Mol Physiol; 2003 Nov; 285(5):L986-95. PubMed ID: 12754183
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
